EOLS - CIK 0001570562
The table below shows Evolus, Inc.'s balance sheet by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $49.79M | $43.52M | $61.74M | $67.89M | $85.03M | $93.67M |
| Short-term investments | - | - | - | - | - | - |
| Receivables | $52.22M | $50.44M | $47.71M | $47.45M | $44.64M | $43.15M |
| Inventory | $24.80M | $32.87M | $26.46M | $10.03M | $14.89M | $13.38M |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Total current assets |
| $138.92M |
| $134.89M |
| $144.97M |
| $131.72M |
| $150.36M |
| $158.13M |
| Property, plant & equipment | $5.33M | $5.13M | $3.65M | $3.25M | $2.31M | $2.28M |
| Goodwill | $21.21M | $21.21M | $21.21M | $21.21M | $21.21M | $21.21M |
| Total assets | $220.65M | $219.00M | $228.80M | $213.36M | $229.61M | $233.77M |
| Accounts payable | $19.53M | $22.96M | $23.31M | $16.18M | $13.84M | $10.28M |
| Total current liabilities | $68.02M | $66.71M | $63.75M | $56.23M | $60.81M | $54.12M |
| Long-term debt | $156.41M | $145.78M | $145.47M | $121.81M | $121.21M | $120.92M |
| Total liabilities | $249.43M | $247.76M | $247.46M | $219.97M | $223.72M | $214.46M |
| Retained earnings | -$671.71M | -$661.17M | -$645.43M | -$628.29M | -$602.61M | -$583.44M |
| Total equity | -$28.78M | -$28.76M | -$18.65M | -$6.60M | $5.89M | $19.31M |